key: cord-0701095-xp8x6sit authors: Nanna, Michael G.; Peterson, Eric D. title: Racial Differences in Long-Term Cardiovascular Outcomes: The Need to Move From Description to Action date: 2020-07-13 journal: JACC Cardiovasc Interv DOI: 10.1016/j.jcin.2020.05.043 sha: 59716eda05c7d10c7297a8a414b5f3e5265dc1e8 doc_id: 701095 cord_uid: xp8x6sit [Figure: see text] The Need to Move From Description to Action* Michael G. Nanna, MD, Eric D. Peterson, MD, MPH I t has been more than 3 decades since reports of racial differences in cardiovascular disease (CVD) treatment and outcomes first emerged (1, 2) . These disturbing findings garnered much attention and prompted significant research interest. In the years that followed, several things have become clear. Relative to whites, blacks have a higher burden of CVD risk factors, including hypertension, diabetes, and obesity (3) . These factors contribute to earlier onset CVD among blacks, lower rates of coronary revascularization, and most alarmingly, significantly higher CVD mortality rates than whites (4) (5) (6) . In this issue of JACC: Cardiovascular Interventions, The unique study design utilized by the investigators addresses some limitations of prior cohort studies. Specifically, the RCT populations had highquality clinical data, core lab angiographic readings, and formal adjudication of outcomes. The use of RCT data also increases the homogeneity of study population and treatment received across racial groups. All were selected and agreed to participate in a trial, all underwent PCI, and the type of coronary stent used was adjusted for. Additionally, the investigators looked at multiple short-and long-term CVD outcomes. Although the study was well conducted, the selected trial population also creates some challenges. Those enrolled in RCTs are typically healthier, receive better care, and as a result, have better outcomes than those in the community. The trials also enrolled a low proportion of black patients, which increases the risk of selection bias. Additionally, the trials classified those of Hispanic ethnicity as a separate race category, which is not consistent with current standards. Yet, despite these strengths and weaknesses, the bottom-line conclusions from the Golomb Interventions author instructions page. (11, 12) . The combined influence of these drivers is substantial. Blacks in this country are less likely to be treated by cardiovascular subspecialists and more likely to be treated at low-volume and lowperforming centers (13) . Blacks are also less likely than whites to receive evidence-based CVD prevention therapies, including blood pressure control (14) and use of lipid-lowering therapies (15) . Lower prescription rates as well as lower persistence account for these differences (16) . Again, the current study did not have access to downstream care patterns, yet differential access to specialty care and prevention therapies likely contributed to the observed racial differences in long-term CVD outcomes. The study by Golomb et al. (7) should also not be viewed in isolation but rather as part of a broader and consistent message of widespread racial disparities in Yet, rather than merely observe these differences over and over again for the next 30 years, there is an urgent need for action to address these, both locally and nationally. The recent unfortunate death of George Floyd has helped awaken the nation's consciousness to urgently address longstanding racial In-hospital mortality rates from acute myocardial infarction by race in U.S. hospitals: findings from the National Hospital Discharge Survey Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs State of disparities in cardiovascular health in the United States Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? The cardiovascular state of the union: confronting healthcare disparities Temporal trends in racial differences in 30-day readmission and mortality rates after acute myocardial infarction among Medicare beneficiaries Prognostic impact of race in patients undergoing PCI: analysis from 10 randomized coronary stent trials ARMC 5 variants and risk of hypertension in blacks: MH-GRID study Cardiovascular health in African Americans: a scientific statement from the American Heart Association Socioeconomic status and cardiovascular outcomes Race, socioeconomic status, and life expectancy after acute myocardial infarction Trends in racial/ethnic and nativity disparities in cardiovascular health among adults without prevalent cardiovascular disease in the United States Quality and equity of care in U.S. hospitals US trends in prevalence, awareness, treatment, and control of hypertension Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the patient and provider assessment of lipid management registry Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users COVID-19 and African Americans Eliminating racial and ethnic disparities in cardiac care Social Risk factors and equity in Medicare payment Impact of a pay-for-performance program on care for black patients with hypertension: important answers in the era of the Affordable Care Act The effects of race and racial concordance on patient physician communication: a systematic review of the literature Does diversity matter for health? Experimental evidence from Oakland Diversity matters Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients